SEC Form 4 research
| Issuer | CRISPR Therapeutics AG |
|---|---|
| Tickers | CRSP |
| Reporting owners | 47 |
| Officers and directors | 17 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-04 | Sakhamuri Sivakesava | A | 40,000 | $0 | Not reported |
| 2026-11-06 | 2026-11-04 | Sakhamuri Sivakesava | A | 90,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Silver Andrew Jacob | A | 9,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Silver Andrew Jacob | A | 18,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | KASINGER JAMES R. | A | 9,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | KASINGER JAMES R. | A | 18,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Kulkarni Samarth | A | 28,750 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Kulkarni Samarth | A | 57,500 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Patel Naimish | A | 12,000 | $0 | Not reported |
| 2026-10-28 | 2026-10-26 | Patel Naimish | A | 24,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.